Immunotherapy Best Practices: Overcoming Clinical Challenges and Enhancing Treatment in Solid Tumors

Target Audience
Medical, surgical, and radiation oncologists; primary care physicians; internal medicine specialists; health care professionals including oncology pharmacists, oncology advanced practice nurses and physician assistants, and other health care providers who participate in the care of patients with cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

Examine the variety of biomarkers associated with immune checkpoint inhibitor therapy
Select appropriate, evidence-based testing modalities for patients who are potential candidates for immune checkpoint inhibitor therapy and interpret testing results effectively